Does an educational intervention on health risks of vaping work?
An educational intervention was successful in improving high school students' knowledge on the risks associated with vaping. Knowledge on health risk was the most common reported reason for which students would stop vaping. Effectiveness of an educational intervention on health risks of vaping for high school-aged adolescents
What makes vaping more appealing?
The researchers also found that certain messaging content currently being used, especially imagery related to candy and flavor, increases the appeal of vaping and should be avoided when designing prevention messages. The findings appeared May 9, 2022, in the journal Tobacco Control.
How effective are vaping prevention ads for teens?
The online study asked 1,501 teens to rate seven randomly selected vaping prevention ads from a pool of more than 200 ads. Vaping prevention ads that clearly communicated the health harms of vaping, or compared vaping to cigarette smoking, were comparatively more effective.
What is the vaping prevention resource?
The study utilized UNC’s Vaping Prevention Resource, a website designed to provide practitioners, researchers and communities with vaping prevention media content from around the world, as well as strategies and resources for youth vaping prevention.
What is statistical method?
What is the Advisory Committee for Immunization Practices?
Is observational study more likely to be biased?
Is the CDC using the ve network?
See 1 more
About this website
How is vaping measured?
The amount of nicotine in a vape juice is measured as a percentage of the juice's total composition. For instance, a 5% nicotine concentration in a 300 ml bottle of e-juice essentially means that the actual amount of liquid nicotine in the vape juice is 15 ml.
How do vape companies measure puffs?
Puff duration has also been measured in button-activated e-cigarettes by measuring the length of time the heating element is activated by the user12,13. Puffing topography data have been extensively studied for users of combustible cigarettes, and the impact on smoking experience has been widely reported9,11,14.
How do I know what strength my vape is?
Nicotine strength in mg/mL If you need to work out the total amount of nicotine in a bottle or in a tank, just multiply the strength in mg/mL by the number of milliliters of it you have. For example, if you fill up a 5 mL vape tank with 6 mg/mL e-liquid, you have 5 mL × 6 mg/mL = 30 mg of nicotine in your tank.
How effective is vaping?
For example, an analysis of 61 studies found that e-cigarette use was more effective than other approaches to quitting smoking. The study authors estimated that out of every 100 people who tried to quit smoking by vaping, nine to 14 might be successful.
How many puffs a day is normal vape?
After removing days of use with less than 5 puffs, the median rises to 140 puffs / day. The number of puffs per day varied considerably from one user to another. However, it should be noted that whereas a large minority of individuals take more than 140 puffs per day, only 14.60% of daily usage exceeds 300 puffs.
How many puffs of a vape is equal to a cigarette?
10 puffsTypically, manufacturers advise that 10 puffs on your vape are about the same as 10 puffs on your cigarette. They further speculate that 10 puffs are all you take on one cigarette. Of course, this varies based on how big your puffs are, how strong your vape device is, and how much nicotine you are using.
Is 5% a strong vape?
There is no question about it, the vape juices out there that contain 5% nicotine in them are definitely strong. They are, in fact, very strong. They're really only made possible through nicotine salts, which have been carefully engineered over the years to vape smoothly at high concentrations.
Is 20mg vape too strong?
Is 20mg Nicotine a lot? A 20mg/ml nicotine strength is usually advised for smokers who used to smoke around a pack of cigarettes a day. For vapers who smoke less than a pack a day, lower strengths are more likely to be better for you. 20mg/ml of nicotine may be too much for many vapers if they only smoke lightly.
Is a 20mg vape strong?
It's a good place to start to get you used to vaping and will give you enough to keep the cravings away. 18mg nicotine through to 20mg nicotine - This is a high nicotine level for people who are getting through a serious number of cigarettes, by this we mean over a pack a day.
Can your lungs cure from vaping?
Breathing in the harmful chemicals from vaping products can cause irreversible (cannot be cured) lung damage, lung disease and, in some cases, death.
Will I feel better if I vape instead of smoking?
Vaping is a way to quit cigarettes by getting nicotine with fewer of the toxins that come from burning tobacco. You get to stay social, spend less, and once you've quit smoking you'll feel better for it. Although vaping's much less harmful than smoking, it's not harmless.
What is the healthiest vape?
The PAX 3 is consistently ranked one of the healthiest vapes, and it's an incredibly customizable conduction vaporizer suitable for dry herb and wax.
How many cigarettes is 100 puffs of vape?
ten cigarettesAn average e-juice bottle is 1 millilitre. A single millilitre contains around 100 puffs. One hundred puffs are about ten cigarettes. So, 2 millilitres of vape juice is the equivalent of a single pack of cigarettes in terms of smoking/vaping.
How many cigarettes are 600 puffs?
45 cigarettesEach Elf Bar 600 disposable device provides up to 600 puffs, which is equal to approximately 45 cigarettes.
How long should 600 puffs last?
Each Elf Bar contains around 600 puffs. Studies have found that vapers usually take 132 to 140 puffs a day. So, if you're averaging about 135 puffs a day, one disposable Elf Bar would last you a little over four days. However, you should also keep in mind that this number is subjective.
How many seconds is considered a puff?
... "puff" was defined as the time it takes a person to raise the cigarette to their lips, inhale, and then lower their arm back to the resting position. Therefore, we conservatively define a minimum puff duration consisting of 0.75 seconds (shown in Figure 4a).
CDC Seasonal Flu Vaccine Effectiveness Studies | CDC
Seasonal Influenza Vaccine Effectiveness, 2005-2016 - CDC. Supporting Research. Belongia EA, Kieke BA, Donahue JG, et al. Effectiveness of inactivated influenza vaccines varied substantially with antigenic match from the 2004-2005 season to the 2006-2007 season.
Flu Vaccine Effectiveness and Duration for Adults and Children - Healthline
Flu vaccine effectiveness changes from year to year due to several factors such as viral evolution and what subtype of influenza is predominant in a given year.
Vaccine Effectiveness: How Well Do Flu Vaccines Work? | CDC
How effective are flu vaccines? CDC conducts studies each year to determine how well influenza (flu) vaccines protect against flu. While vaccine effectiveness (VE) can vary, recent studies show that flu vaccination reduces the risk of flu illness by between 40% and 60% among the overall population during seasons when most circulating flu viruses are well-matched to those used to make flu vaccines.
What does vaccine efficacy mean? - Medical News Today
Vaccine efficacy measures the percentage reduction of a disease in a clinical trial. Vaccine effectiveness measures how well a vaccine works in the real world.
Vaccine efficacy, effectiveness and protection - World Health Organization
This article is part of a series of explainers on vaccine development and distribution. Learn more about vaccines – from how they work and how they’re made to ensuring safety and equitable access – in WHO’s Vaccines Explained series.. COVID-19 vaccines have proven to be safe, effective and life-saving.
Abstract
The primary objective of this research was to identify if an educational intervention increased the knowledge of high school adolescents on the social and health risks associated with vaping. The secondary objectives included measuring the prevalence of vaping habits and the attitudes of adolescents on the safety of vaping.
Background
Published studies have noted a substantial rise in the use of vaping products by adolescents, with the 2018 National Youth Tobacco Survey reporting that more than 3.6 million adolescents use vaping products, an increase of approximately 1.5 million from recent years.
Objective
The primary objective of this research was to determine if a targeted educational intervention performed by student pharmacists increased the knowledge of high school adolescents on the social and health risks associated with vaping.
Methods
This study was conducted with adolescents at 1 high school in western North Carolina. The project was approved by the Wingate University Research Review Board (RRB). Participants included adolescents enrolled in physical education classes who provided consent, or parental consent if under the age of 18 years.
Results
There were usable data on 235 participants, out of the 236 who gave consent. Most of the sample reported being men (52.77%) and in the ninth grade (53.19%). The adolescents reported vaping multiple times per day (n = 41) and socially (n = 31), and the most common reason they vaped for was stress reduction (n = 48).
Discussion
The educational intervention resulted in a statistically significant increase in knowledge, evidenced by the gain in knowledge, especially among older adolescents. However, the survey tool was unvalidated, and therefore it was difficult to assess how much improvement was required for an actual change versus statistical significance.
Conclusion
In conclusion, this intervention, conducted by student pharmacists, was effective at providing evidence-based information to adolescents to improve knowledge, meeting the primary objective. The data collected suggest that this group of adolescents was misinformed on the risks of vaping products.
Abstract
The primary objective of this research was to identify if an educational intervention increased the knowledge of high school adolescents on the social and health risks associated with vaping. The secondary objectives included measuring the prevalence of vaping habits and the attitudes of adolescents on the safety of vaping.
Background
Published studies have noted a substantial rise in the use of vaping products by adolescents, with the 2018 National Youth Tobacco Survey reporting that more than 3.6 million adolescents use vaping products, an increase of approximately 1.5 million from recent years.
Objective
The primary objective of this research was to determine if a targeted educational intervention performed by student pharmacists increased the knowledge of high school adolescents on the social and health risks associated with vaping.
Methods
This study was conducted with adolescents at 1 high school in western North Carolina. The project was approved by the Wingate University Research Review Board (RRB). Participants included adolescents enrolled in physical education classes who provided consent, or parental consent if under the age of 18 years.
Results
There were usable data on 235 participants, out of the 236 who gave consent. Most of the sample reported being men (52.77%) and in the ninth grade (53.19%). The adolescents reported vaping multiple times per day (n = 41) and socially (n = 31), and the most common reason they vaped for was stress reduction (n = 48).
Discussion
The educational intervention resulted in a statistically significant increase in knowledge, evidenced by the gain in knowledge, especially among older adolescents. However, the survey tool was unvalidated, and therefore it was difficult to assess how much improvement was required for an actual change versus statistical significance.
Conclusion
In conclusion, this intervention, conducted by student pharmacists, was effective at providing evidence-based information to adolescents to improve knowledge, meeting the primary objective. The data collected suggest that this group of adolescents was misinformed on the risks of vaping products.
Study Shows Anti-Vaping Advertising Campaigns Are Effective in Educating Youth About Tobacco Dangers
Young people who see anti-vaping advertisements and prevention campaigns are more likely to have accurate e-cigarette knowledge, which can lead to a decrease in tobacco use and consequently, lung cancer diagnoses, according to a July 2021 study from the Truth Initiative, an organization devoted to educating youth about smoking and tobacco industries..
Additional ONS Resources About Tobacco Prevention and Education
The Centers for Disease Control and Prevention reported that people who smoke cigarettes are 15–30 times more likely to get lung cancer or die from lung cancer than people who do not smoke, and as new forms of tobacco use and consumption are produced, marketed, and sold—especially to minors—healthcare providers are left to deal with the addiction, disease, and death that Big Tobacco has left in its wake of profits..
What is statistical method?
Statistical methods are used to account for differences in age, race and underlying medical conditions that might influence vaccine effectiveness. Estimates are reported annually, and often, an early estimate is reported during the season.
What is the Advisory Committee for Immunization Practices?
Once an influenza vaccine has been licensed by FDA, recommendations are typically made by CDC’s Advisory Committee for Immunization Practices (ACIP) for its routine use. For example, ACIP now recommends annual influenza vaccination for all U.S. residents aged 6 months and older.
Is observational study more likely to be biased?
Results from observational studies are more likely to be affected by various forms of bias ( see above for definition) than are results from RCT studies. Therefore, results from observational studies can be more difficult to interpret. Bias can be reduced through careful study designs and analyses of data collected through observational studies. Observational studies of flu vaccine effectiveness are subject to at least three forms of bias: confounding, selection bias, and information bias.
Is the CDC using the ve network?
Over the past few years, CDC has conducted VE studies using multiple networks, including the U.S. Flu VE Network, the Hospitalized Adult Flu Vaccine Effectiveness Network (HAIVEN), the Flu and Other Viruses in the Acutely Ill (IVY) network, the National Vaccine Surveillance Network (NVSN), and the VISION VE Network. For this upcoming winter, HAIVEN will no longer be used. HAIVEN looked at how well flu vaccines protect against flu-related hospitalization among adults aged 18 and older. HAIVEN ended enrollment on July 31, 2021, but CDC will continue to collect information on adults hospitalized with flu through its other VE networks, including IVY and VISION. IVY consists of 21 large, adult hospitals in 20 U.S. cities and was originally created in 2019 to estimate how well the flu vaccine works at preventing severe flu illness among intensive care unit (ICU) patients. As of April 1, 2021, IVY has expanded to enroll all adults hospitalized with COVID-19. During the 2021-2022 flu season, the network will also enroll patients hospitalized with flu. NVSN collects vaccine effectiveness data on pediatric hospitalizations with laboratory confirmed flu in children 18 years of age and younger. The VISION VE Network collects data on emergency department visits, hospitalizations, and intensive care unit (ICU) admissions. The network was established in 2019 and includes the following eight U.S. sites:
What is statistical method?
Statistical methods are used to account for differences in age, race and underlying medical conditions that might influence vaccine effectiveness. Estimates are reported annually, and often, an early estimate is reported during the season.
What is the Advisory Committee for Immunization Practices?
Once an influenza vaccine has been licensed by FDA, recommendations are typically made by CDC’s Advisory Committee for Immunization Practices (ACIP) for its routine use. For example, ACIP now recommends annual influenza vaccination for all U.S. residents aged 6 months and older.
Is observational study more likely to be biased?
Results from observational studies are more likely to be affected by various forms of bias ( see above for definition) than are results from RCT studies. Therefore, results from observational studies can be more difficult to interpret. Bias can be reduced through careful study designs and analyses of data collected through observational studies. Observational studies of flu vaccine effectiveness are subject to at least three forms of bias: confounding, selection bias, and information bias.
Is the CDC using the ve network?
Over the past few years, CDC has conducted VE studies using multiple networks, including the U.S. Flu VE Network, the Hospitalized Adult Flu Vaccine Effectiveness Network (HAIVEN), the Flu and Other Viruses in the Acutely Ill (IVY) network, the National Vaccine Surveillance Network (NVSN), and the VISION VE Network. For this upcoming winter, HAIVEN will no longer be used. HAIVEN looked at how well flu vaccines protect against flu-related hospitalization among adults aged 18 and older. HAIVEN ended enrollment on July 31, 2021, but CDC will continue to collect information on adults hospitalized with flu through its other VE networks, including IVY and VISION. IVY consists of 21 large, adult hospitals in 20 U.S. cities and was originally created in 2019 to estimate how well the flu vaccine works at preventing severe flu illness among intensive care unit (ICU) patients. As of April 1, 2021, IVY has expanded to enroll all adults hospitalized with COVID-19. During the 2021-2022 flu season, the network will also enroll patients hospitalized with flu. NVSN collects vaccine effectiveness data on pediatric hospitalizations with laboratory confirmed flu in children 18 years of age and younger. The VISION VE Network collects data on emergency department visits, hospitalizations, and intensive care unit (ICU) admissions. The network was established in 2019 and includes the following eight U.S. sites:
